AT310938B - Verfahren zur Herstellung eines neuen lokalanästhetischen Mittels mit langer Wirkungsdauer - Google Patents

Verfahren zur Herstellung eines neuen lokalanästhetischen Mittels mit langer Wirkungsdauer

Info

Publication number
AT310938B
AT310938B AT1084871A AT1084871A AT310938B AT 310938 B AT310938 B AT 310938B AT 1084871 A AT1084871 A AT 1084871A AT 1084871 A AT1084871 A AT 1084871A AT 310938 B AT310938 B AT 310938B
Authority
AT
Austria
Prior art keywords
preparation
action
local anesthetic
long duration
anesthetic agent
Prior art date
Application number
AT1084871A
Other languages
German (de)
English (en)
Inventor
J F Adams Herbert
H Takman Bertil
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Application granted granted Critical
Publication of AT310938B publication Critical patent/AT310938B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT1084871A 1971-01-26 1971-12-17 Verfahren zur Herstellung eines neuen lokalanästhetischen Mittels mit langer Wirkungsdauer AT310938B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10994271A 1971-01-26 1971-01-26

Publications (1)

Publication Number Publication Date
AT310938B true AT310938B (de) 1973-10-25

Family

ID=22330411

Family Applications (2)

Application Number Title Priority Date Filing Date
AT1084871A AT310938B (de) 1971-01-26 1971-12-17 Verfahren zur Herstellung eines neuen lokalanästhetischen Mittels mit langer Wirkungsdauer
AT1084971A AT310939B (de) 1971-01-26 1971-12-17 Verfahren zur Herstellung eines neuen lokalanästhetischen Mittels mit langer Wirkungsdauer

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT1084971A AT310939B (de) 1971-01-26 1971-12-17 Verfahren zur Herstellung eines neuen lokalanästhetischen Mittels mit langer Wirkungsdauer

Country Status (18)

Country Link
AT (2) AT310938B (enExample)
AU (1) AU465875B2 (enExample)
BE (2) BE776769A (enExample)
BR (2) BR7108429D0 (enExample)
CA (2) CA986012A (enExample)
DD (2) DD96144A5 (enExample)
DE (2) DE2163054C3 (enExample)
DK (2) DK130389B (enExample)
ES (2) ES398108A1 (enExample)
FR (2) FR2123277B1 (enExample)
GB (1) GB1370904A (enExample)
HU (2) HU162185B (enExample)
IE (2) IE35937B1 (enExample)
LU (1) LU64664A1 (enExample)
NL (2) NL7117401A (enExample)
NO (2) NO135891C (enExample)
SE (2) SE391286B (enExample)
ZA (2) ZA718326B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition
US6030974A (en) * 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia
WO1998051290A2 (en) * 1997-05-16 1998-11-19 Children's Medical Center Corporation Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent
RU2277097C1 (ru) * 2004-12-27 2006-05-27 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Высокомеченный тритием дигидрохлорид [3h]сакситоксина
CN101563079B (zh) 2006-03-27 2012-12-05 威克斯药业有限公司 钠通道阻滞剂在制备治疗由于化疗而产生的神经病理性疼痛的药物中的用途
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
KR20210062693A (ko) 2013-03-15 2021-05-31 더 칠드런스 메디칼 센터 코포레이션 지속성 국소 마취용 네오삭시톡신 조합 제형

Also Published As

Publication number Publication date
BR7108428D0 (pt) 1973-06-14
DK131606B (da) 1975-08-11
DD96144A5 (enExample) 1973-03-12
DE2163054B2 (de) 1978-06-01
BE776768A (fr) 1972-06-16
HU162185B (enExample) 1973-01-29
AU3710171A (en) 1973-06-28
IE35910L (en) 1972-07-26
ES398109A1 (es) 1975-03-16
ZA718326B (en) 1972-09-27
SE391127B (sv) 1977-02-07
DK131606C (da) 1976-01-12
DD96400A5 (enExample) 1973-03-20
FR2123277B1 (enExample) 1975-06-13
NO135892C (no) 1978-05-16
DE2163054A1 (de) 1974-05-02
BR7108429D0 (pt) 1973-06-14
DK130389C (enExample) 1975-07-14
DE2163055A1 (de) 1972-10-12
HU162347B (enExample) 1973-02-28
NO135892B (enExample) 1977-03-14
IE35937L (en) 1972-07-26
IE35910B1 (en) 1976-06-23
IE35937B1 (en) 1976-07-07
FR2123277A1 (enExample) 1972-09-08
BE776769A (fr) 1972-06-16
AU3710071A (en) 1973-06-28
NL7117401A (enExample) 1972-07-28
DK130389B (da) 1975-02-17
FR2123278A1 (enExample) 1972-09-08
NO135891C (no) 1978-05-16
ZA718327B (en) 1972-09-27
NL7117404A (enExample) 1972-07-28
GB1370904A (en) 1974-10-16
FR2123278B1 (enExample) 1975-08-01
ES398108A1 (es) 1975-03-01
NO135891B (enExample) 1977-03-14
CA986012A (en) 1976-03-23
AU465875B2 (en) 1975-10-09
SE391286B (sv) 1977-02-14
DE2163054C3 (de) 1979-02-01
AT310939B (de) 1973-10-25
LU64664A1 (enExample) 1972-08-23
CA983850A (en) 1976-02-17

Similar Documents

Publication Publication Date Title
AT318610B (de) Verfahren zur Herstellung von neuen Carboxamidotetrazol-Derivaten
AT318548B (de) Verfahren zur Herstellung eines Deshydratisierkatalysators
AT319607B (de) Verfahren zur Herstellung von neuen Polyepoxydpolysiloxanverbindungen
AT320642B (de) Verfahren zur Herstellung von neuen Oxazolidonen
AT329531B (de) Verfahren zur herstellung von neuen hydroxycitronensaure-gamma-lactonderivaten
AT305491B (de) Verfahren zur Herstellung eines neuen Kombinationspräparates
AT310939B (de) Verfahren zur Herstellung eines neuen lokalanästhetischen Mittels mit langer Wirkungsdauer
AT315837B (de) Verfahren zur Herstellung von neuen Thiazolidinderivaten
AT317430B (de) Verfahren zur Herstellung eines neuen Antibiotikums und seiner Säureadditionssalze
AT317435B (de) Verfahren zur Herstellung eines antiseborrhoisch wirksamen Mittels
AT312805B (de) Verfahren zur Herstellung eines Sekretin-Präparates
AT325043B (de) Verfahren zur herstellung der neuen 5- oder 7-chlorsulfonylxanthon-2-carbonsäuren
AT315196B (de) Verfahren zur Herstellung von neuen 6-Hydroxy-dihydro-uracilen
AT332538B (de) Verfahren zur herstellung eines 7beta-aminocephalosporins
AT315368B (de) Verfahren zur Herstellung eines neuen Antibioticums
CH537915A (de) Verfahren zur Herstellung eines neuen Östratriols
AT305496B (de) Verfahren zur Herstellung eines blutstillenden Präparats
AT312625B (de) Verfahren zur Herstellung eines neuen Oxazins
AT316753B (de) Verfahren zur Herstellung eines Fibrinolyseaktivators
AT315367B (de) Verfahren zur Herstellung eines neuen Arzneimittels
AT331389B (de) Verfahren zur herstellung eines neuen pharmazeutischen praparates
AT318825B (de) Verfahren zur Herstellung eines neuen Dipeptid-amids
AT331405B (de) Verfahren zur herstellung eines neuen makrocyclischen lactons
AT328074B (de) Verfahren zur herstellung eines neuen antibiotikums
CH484905A (de) Verfahren zur Herstellung eines neuen Lokalanästhetikums

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee